MENU
VNDA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Vanda Pharmaceuticals (VNDA) Earnings Date & Reports

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

VNDA is expected to report earnings to rise 150.00% to -94 cents per share on February 11

Vanda Pharmaceuticals VNDA Stock Earnings Reports
Q4'25
Est.
$-0.95
Q3'25
Beat
by $0.05
Q2'25
Missed
by $0.17
Q1'25
Missed
by $0.48
Q4'24
Beat
by $0.09
The last earnings report on October 29 showed earnings per share of -37 cents, beating the estimate of -43 cents. With 317.74K shares outstanding, the current market capitalization sits at 256.77M.
View a ticker or compare two or three
VNDA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VNDA showed earnings on October 29, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a manufacturer of biopharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2200 Pennsylvania Avenue NW
Phone
+1 202 734-3400
Employees
203
Web
https://www.vandapharma.com